PPARG and Parkinson disease: Treatment with these exosomes demonstrated a notable increase in dopamine and 5-hydroxytryptamine levels, accompanied by elevated PPARγ expression, enhanced sleeping time, reduced awaken time and restoration of mitochondrial membrane potential within the stratum of PD rats [176].